News
A nutraceutical solution to the opioid crisis?
29-Apr-2019 Last updated on 25-Apr-2019 at 15:18 GMT With OptiPEA (Palmitoylethanolamide), Innexus...
Read More
Innexus Nutraceuticals Launches Nutraceutical Palmitoylethanolamide (PEA)
GMP grade Palmitoylethanolamide – OptiPEA® 26-Jun-2019 Nijmegen, The Netherlands –...
Read More
OptiPEA: The absolute safe resort in chronic pain management
26-Jun-2019 Transparency, certification, sustainability, branding. With OptiPEA (palmitoylethanolamide), Innexus Nutraceuticals...
Read More
CBD alternative? PEA-based ingredient takes aim at pain relief after CBD’s ‘novel food’ reclassification
Uncertainty around CBD products’ status in the supplements sector has...
Read More